Our team has conducted market access landscape assessments and developed winning strategies across a broad spectrum of specialties and technologies.
Structural Heart
WATCHMAN, intracardiac devices, valve technologies
Electrophysiology
S-ICD national coverage and premium payment secured
Urology & BPH
Coverage strategy for benign prostatic hyperplasia technologies
Heart Failure & Pulmonary
Remote physiological monitoring, advanced heart failure devices
Radiation Oncology
Economic models, reimbursement strategy, digital health integration
Peripheral Nerve & CAD
Coronary artery disease, peripheral nerve repair, and more
Proven Results: Our Track Record Across Major Therapeutic Areas
Landmark Wins That Define Our Expertise
TCET Coverage Pathway Acceptance
A client was accepted into Medicare's Transitional Coverage for Emerging Technologies (TCET) pathway — one of CMS's most strategic new coverage vehicles for breakthrough devices. This positions the client for national Medicare coverage ahead of standard timelines.
Reversed Non-Coverage for Intracranial Stenting
Successfully reversed Medicare's non-coverage policy for an intracranial stenting clinical study — saving millions of dollars in study costs over a 2–3 year period and preserving a critical evidence-generation program.
RAPID Pathway Pilot Selection
Currently advising a client accepted as a pilot participant in the RAPID coverage pathway — a novel, accelerated Medicare coverage approach designed to reduce time-to-coverage for innovative technologies while supporting evidence development necessary for clinical adoption.
Premium Pricing in Japan for S-ICD
Developed and executed the market access strategy that obtained a price premium for S-ICD in Japan in 2016, resulting in meaningfully increased revenue per procedure in a key international market.
WATCHMAN, S-ICD & Alair National Coverage
Obtained national Medicare coverage for WATCHMAN, S-ICD, and Alair bronchial thermoplasty — securing physician and hospital payments that enabled hundreds of millions in revenue.
PARASHAR B. PATEL, FOUNDER & CEO, MARKET ACCESS STRATEGY, LLC
Parashar is Founder & CEO of Market Access Strategy, LLC. The firm provides market access strategies and health care delivery system and payment policy advice to medical technology firms. Parashar is an accomplished healthcare executive with a demonstrated history of leadership in the medical device industry and public sector. He brings more than 30 years of health policy and market access experience to clients.
Parashar develops efficient and effective strategies to support the adoption and growth of new technology as well as improve the policy environment for medical technologies. His areas of expertise include payment and coverage policy, market access strategies, healthcare delivery systems, medical devices and clinical research.
Parashar previously served as Principal at McDermottPlus, where he advised and supported clients on market access and health policy. Prior to joining McDermottPlus, Parashar served as senior vice president for government affairs and market access at ViewRay, where he led global efforts to drive adoption of MRIdian in cancer treatment. He previously led Boston Scientific’s global teams focused on the development and execution of market access, health economics and public policy strategies for key technologies.
Parashar also held a variety of roles at the Centers for Medicare and Medicaid Services, the American Association of Health Plans, the Office of (then) Senate Majority Leader George J. Mitchell, the US Office of Management and Budget, and Connecticut’s Medicaid agency.
